➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: May 26, 2020

DrugPatentWatch Database Preview

ZORBTIVE Drug Profile

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Summary for Tradename: ZORBTIVE

Patents:	2
Applicants:	1
BLAs:	1
Drug Prices:	Drug price information for ZORBTIVE
Recent Clinical Trials:	See clinical trials for ZORBTIVE

Drug Prices for ZORBTIVE

See drug prices for ZORBTIVE

Recent Clinical Trials for ZORBTIVE

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Center for Human Reproduction	Phase 1/Phase 2
EMD Serono	Phase 4
Northwestern Memorial Hospital	Phase 4

See all ZORBTIVE clinical trials

Patent Text Search: US Patents for ZORBTIVE

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Emd Serono	ZORBTIVE	somatropin recombinant	INJECTABLE;INJECTION	021597	001	2003-12-01	Start Trial	ForSight Vision4, Inc. (Menlo Park, CA)	2029-01-29	DISCN	Orphan	search
Emd Serono	ZORBTIVE	somatropin recombinant	INJECTABLE;INJECTION	021597	001	2003-12-01	Start Trial	Forsight Vision4, Inc. (Menlo Park, CA)	2029-01-29	DISCN	Orphan	search
Emd Serono	ZORBTIVE	somatropin recombinant	INJECTABLE;INJECTION	021597	002	2003-12-01	Start Trial	ForSight Vision4, Inc. (Menlo Park, CA)	2029-01-29	DISCN	Orphan	search
Emd Serono	ZORBTIVE	somatropin recombinant	INJECTABLE;INJECTION	021597	002	2003-12-01	Start Trial	Forsight Vision4, Inc. (Menlo Park, CA)	2029-01-29	DISCN	Orphan	search
Emd Serono	ZORBTIVE	somatropin recombinant	INJECTABLE;INJECTION	021597	003	2003-12-01	Start Trial	ForSight Vision4, Inc. (Menlo Park, CA)	2029-01-29	DISCN	Orphan	search
Emd Serono	ZORBTIVE	somatropin recombinant	INJECTABLE;INJECTION	021597	003	2003-12-01	Start Trial	Forsight Vision4, Inc. (Menlo Park, CA)	2029-01-29	DISCN	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for ZORBTIVE

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
China	103209664	Start Trial
Canada	2807554	Start Trial
Japan	6326124	Start Trial
Japan	6171036	Start Trial
Canada	2757037	Start Trial
Australia	2011285501	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt

Medtronic

Harvard Business School

AstraZeneca

Merck

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.